Publications

2016

Gillespie EF, Matsuno RK, Xu B, Triplett DP, Hwang L, Boero IJ, Einck JP, Yashar C, Murphy JD. Geographic disparity in the use of hypofractionated radiotherapy among elderly women undergoing breast conservation for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2016, in press.
 
Acevedo JR, Fero KE, Wilson B, Sacco AG, Mell LK, Coffey CS, Murphy JD. Cost-effectiveness analysis of elective neck dissection in patients with clinically node-negative oral cavity cancer. J Clin Oncol. 2016, in press.

Boero IJ, Paravati A, Xu B, Cohen EE, Mell LK, Le QT, Murphy JD. The importance of radiation oncologist experience among head-and-neck cancer patients treated with intensity modulated radiation therapy. J Clin Oncol. 2016, 34(7):684-90.
 
Boero IJ, Triplett DP, Paravati A, Hwang L, Matsuno R, Gillespie EF, Yashar CM, Moiseenko V, Einck JP, Mell LK, Parikh SA, Murphy JD. Modern radiation therapy and cardiac outcomes in breast cancer. Int J Radiat Oncol Biol Phys. 2016; 94(4):700-8.
 
Gomez SL, Hurley S, Canchola AJ, Keegan T, Cheng I, Murphy JD, Clarke C, Glaser SL, Martinez ME. Effects of economic resources and marital status on survival after cancer: a population-based study. Cancer. 2016, 122(10):1618-25. 
 
Martinez M, Anderson K, Murphy J, Hurley S, Canchola A, Keegan T, Cheng I, Clarke C, Glaser S, Gomez. Differences in marital status and mortality by race/ethnicity and nativity among California cancer patients. Cancer. 2016, 122(10):1570-8. 
 
Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK. Improved method to stratify elderly cancer patients at risk for competing events. J Clin Oncol. 2016, 34(11):1270-7. 
 
Roeland EJ, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Revta C, Yeung HN, Murphy JD. Patterns of palliative care consultation among elderly cancer patients. J Natl Compr Canc Netw. 2016, 14(4):439-45. 
 
Coe TM, Fero KE, Murphy JD, Fanta PT, Mallory RJ, Tang C, Sicklick JK. Population-based epidemiology of small malignant gastrointestinal stromal tumors in the United States. J Gastrointest Surg. 2016, 20(6):1132-40. 
 
Apisarnthanarax S, Cheng JCH, Jabbour SK, Liauw SL, Murphy JD, Chang DT. Gastrointestinal cancers-changing the standard for rectal cancer and establishing a new standard for liver tumors. Int J Radiat Oncol Biol Phys. 2016, 95(3):930-6.
 

2015

Boero IJ, Paravati A, Triplett DP, Hwang L, Matsuno RK, Mell LK, Murphy JD. The impact of radiotherapy costs on clinical outcomes in breast cancer. Radiother Oncol. 2015; 117(2):393-9.

Paravati A, Boero IJ, Triplett DP, Hwang L, Matsuno RK, Xu B, Mell LK, Murphy JD. Variation in the cost of radiation therapy among Medicare patients with cancer. J Oncol Pract. 2015, 11(5):403-9.

Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Grothey A, Hochster HS, Hunt S, Kamel A, Kirilcuk N, Leong LA, Lin E, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM1 Freedman-Cass D. Rectal Cancer, Version 2.2015. J Natl Compr Canc Netw. 2015 Jun;13(6):719-28.

Heestand GM, Murphy JD, Lowy AM. Approach to Patients With Pancreatic Cancer Without Detectable Metastases. J Clin Oncol. 2015 Jun 1;33(16):1770-1778.

Li Y, Hoisak JD, Li N, Jiang C, Tian Z, Gautier Q, Zarepisheh M, Wu Z, Liu Y, Jia X, Hattangadi-Gluth J, Mell LK, Jiang S, Murphy JD. Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy. Med Dosim. 2015 May 19. pii: S0958-3947(15)00035-7.

Murphy JD*, Ma GL* (co-first authorship), Baumgartner JM, Madlensky L, Burgoyne AM, Tang CM, Martinez ME, Sicklick JK. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study. Cancer. 2015 Apr 30.

Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell LK, Murphy JD. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer. 2015 Apr 15;121(8):1303-11.

2014

Ma GL*, Murphy JD* (co-first authorship), Martinez ME, Sicklick JK. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based analysis. Cancer Epidemiol Biomarkers Prev 2014, in press.

Rahn DA, Mundt AJ, Murphy JD, Schiff D, Adams J, Murphy KT. Clinical outcomes of palliative radiotherapy for children. Pract Radiat Oncol 2014, in press.

Shultz DB, Trakul N, Abelson JA, Murphy JD, Maxim PG, Le QT, Loo BW Jr, Diehn M. Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. Clin Lung Cancer, 2014, in press.

Yeung HN, Mitchell W, Roeland E, Xu B, Mell LK, Le QT, Murphy JD. Palliative radiation before hospice: the long and short of it. J Pain Symptom Manage, 2014, in press.

Paravati AJ, Murphy JD. Cost-effectiveness in radiation oncology: an uncomfortable but necessary question. Int J Radiat Oncol Biol Phys, 2014, in press.

Carmona R, Gulaya S, Murphy JD, Rose BS, Wu J, Noticewala S, McHale M, Yashar CM, Vaida F, Mell LK. Population-based competing risk model for early stage endometrial cancer. Int J Radiat Oncol Biol Phys, 2014, in press.

Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell LK, Murphy JD. Age disparity in palliative radiotherapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys, 2014, in press.

Sonier M, Gete E, Herbert C, McKenzie M, Murphy J, Moiseenko V. Intensity-modulated stereotactic radiosurgery for arteriovenous malformations: guidance for treatment planning. Radiother Oncol, 2014, in press.

Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, Messersmith W, Mulcahy MF,Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass DA; National Comprehensive Cancer Network. Colon cancer, version 3.2014.;J Natl Compr Canc Netw. 2014 Jul;12(7):1028-59.

2013

Paravati AJ, Healy E, Murphy JD, Song W, Hattangadi-Gluth J. Stereotactic body radiation therapy for primary hepatic malignancies and liver metastases. Transl Cancer Res 2013;2(6):507-520.

Tang C, Chan C, Jiang W, Murphy JD, Colevas AD, Pinto H, Lee-Enriquez N, Kong C, Le QT. Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer. Head & Neck 2014, in press.

Simpson DR, Martinez ME, Gupta S, Hattangadi-Gluth J, Mell LK, Heestand G, Fanta P, Ramamoorthy S, Le QT, Murphy JD. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer. J Natl Cancer Inst 2013;105(23):1814-20.

Harris JP, Murphy JD, Le QT, Loo BW, Diehn M. A population-based comparative effectiveness study of intensity-modulated versus three-dimensional conformal radiation therapy in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2013, in press.

Murphy JD, Hattangadi-Gluth J, Song WY, Vollans E, Camborde ML, Kosztyla R, Loewen SK, Crumley C, Moiseenko V. Liver toxicity prediction with stereotactic body radiotherapy: the impact of accounting for fraction size. Pract Radiat Oncol 2013, in press.

Jiang W, Murphy J, Van de Rijn M, Donaldson SS. Secondary breast angiosarcoma and germ line BRCA mutations: discussion of genetic susceptibility. J Radiat Oncol 2013;2(3): 331-335.

White EC,  Murphy JD, Chang DT, Koong AC. Reduced toxicity in inflammatory bowel disease patients treated with intensity modulated radiation therapy (IMRT). Am J Clin Oncol 2014, in press.

Tang C, Komakula S, Chan C, Murphy JD, Kong C, Jensen KC, Le QT. Radiologic assessment of retropharyngeal node involvement in oropharyngeal carcinomas stratified by HPV status. Radiother Oncol 2013;109(2):293-6.

Hiniker SM, Roux A, Murphy JD, Harris JP, Tran PT, Kapp DS, Kidd EA. Primary Squamous Cell Carcinoma of the Vagina: Prognostic Factors, Treatment Patterns, and Outcomes. Gynecol Oncol 2013;131(2):380-5.

Hong JC, Murphy JD, Wang SJ, Koong AC, Chang DT. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis. Ann Surg Oncol. 2013;20(12):3999-4007.

Shultz DB, Zeidan YH, Murphy JD, Hara W, Kaplan MJ, Le QT, Chang DT. Radiotherapy for adenoid cystic carcinomas of the head and neck: clinical outcomes and patterns of failure. J Radiat Oncol, 2013, in press.

Zeidan YH, Shultz DB, Murphy JD, An Y, Chan C, Kaplan MJ, Colevas AD, Kong C, Chang DT, Le QT. Postoperative radiation therapy for minor salivary gland carcinomas of the head and neck: long term outcomes. The Laryngoscope, 2013;123(11):2675-80.

Liu MB, Eclov NC, Trakul N, Murphy J, Diehn M, Le QT, Dieterich S, Maxim PG, Loo BW. Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors. Pract Radiat Oncol 2013;3(4): 294-300.

Murphy JD, Nelson LM, Chang DT, Mell LK, Le QT. Inequality in palliative radiotherapy: a population-based study. J Oncol Pract 2013;9(5):e220-7.

2012

Abelson JA, Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EG, Quon A, Le QT, Diehn M, Loo BW. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative. Lung Cancer 2012;78(3):219-24.

Taniguchi CM, Murphy JD, Eclov N, Atwood TF, Kielar K, Christman-Skieller C, Mok E, Xing L, Koong AC, Chang DT. Dosimetric analysis of organs at risk in during expiratory gating during stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 2013;85(4):1090-5.

Hunter KU, Feng FY, Griffith KA, Francis IR, Lawrence TS, Desai S, Murphy JD, Zalupski MM, Ben-Josef E. Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2012;83(3): 921-6.

Tang C, Fischbein NJ, Murphy JD, Chu KP, Bavan B, Dieterich S, Hara W, Kaplan MJ, Colevas D, Le QT. Stereotactic radiosurgery for retreatment of gross perineural invasion in recurrent cutaneous squamous cell carcinoma of the head and neck. Am J Clin Oncol 2012;36(3):293-8.

Abelson JA, Murphy J, Loo Jr. BW, Chang D, Wiegner E, Hancock S, Chang SD, Le QT, Soltys SG, Gibbs IC. Esophageal tolerance to high-dose stereotactic ablative radiotherapy. Dis Esophagus 2012;25(7):623-9.

Chu KP*, Murphy JD* (co-first authorship), La TH, Krakow T, Iagaru A, Graves EE, Hsu A, Maxim PG, Loo BW, Chang DT, Le QT. Prognostic value of metabolic tumor volume and velocity in predicting head and neck cancer outcomes. Int J Radiat Oncol Biol Phys 2012;83(5):1521-7.

Tang C*, Murphy JD* (co-first authorship), Khong B, La TH, Kong C, Fischbein NJ, Colevas AD, Iagaru AH, Graves EE, Le QT. Validation that metabolic tumor volume predicts outcome in head and neck cancer. Int J Radiat Oncol Biol Phys 2012;83(5):1514-20.

Abelson JA, Murphy JD, Minn AY, Chung MP, Fisher GA, Ford JM, Kunz P, Norton JA, Visser BC, Poultsides GA, Koong AC, Chang DT. Intensity modulated radiation therapy for pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 2012;82(4):e595-601.

Abelson JA, Murphy JD, Wiegner EA, Abelson D, Sandman DN, Boas FE, Hristov D, Daly ME, Chang DT, Loo BW, Hara W, Le QT. Evaluation of a metal artifact reduction technique in tonsillar cancer delineation. Practical Radiation Oncology 2011;2(1): 27-34.

Meng X, Loo BW, Ma L, Murphy JD, Sun X, Yu J. Molecular imaging with 11C-PD153035 PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: A pilot study. J Nucl Med 2011;52(10):1573-9.

Wiegner EA, Daly ME, Murphy JD, Abelson J, Chapman CH, Yu Y, Colevas AD, Kaplan MJ, Fischbein N, Le QT, Chang DT. Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: Clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2012;83(1):243-51.

Murphy JD, Chang DT, Abelson J, Daly ME, Yeung HN, Nelson LM, Koong AC. Cost effectiveness of radiotherapy in locally advanced pancreatic cancer. Cancer 2012: 118(4):1119-29.

2011

Das M, Donington JS, Murphy J, Kozak M, Whyte RI, Shrager JB, Hoang CD, Zhou L, Le QT, Loo Jr. BW, Wakelee H. The trimodality approach: results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection followed by consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer (NSCLC). Clin Lung Cancer 2011; 12(5):280-5.

Johnston E, Diehn M, Murphy J, Loo B, Maxim P. Reducing 4D CT artifacts using optimized sorting based on anatomic similarity. Medical Physics 2011; 38(5):2424-9.

Daly ME, Murphy JD, Mok E, Christman-Skieller C, Chang DT, Koong AC. Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer: Are current margin guidelines adequate for conformal therapy? Practical Radiation Oncology. 2011;1(2): 85-94.

Murphy JD, Chisholm KM, Daly ME, Wiegner EA, Truong D, Iagaru A, Maxim PG, Loo BW, Graves EE, Kaplan MJ, Kong C, Le QT. Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity. Radiother Oncol 2011; 101(3):356-61.

Kozak M, Murphy JD, Schipper ML, Donington JS, Zhou L, Whyte RI, Shrager JB, Hoang C, Bazan J, Maxim PG, Graves EE, Diehn M, Hara W, Quon A, Le QT, Wakelee HA, Loo, Jr. BW. Tumor volume as an imaging-based predictor of outcome in preoperative chemoradiotherapy and surgery for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011;6: 920–926.

Maxim PG, Loo BW, Murphy JD, Chu KP, Hsu A, Le QT. Good concordance between on-board imaging and an optically guided stereotactic positioning system for paranasal sinus and skull base radiotherapy. Int J Radiat Oncol Biol Phys 2011;81(4):1153-9.

Daly ME, Le QT, Kozak MM, Maxim PG, Murphy JD, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ, Chang DT. Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control. Int J Radiat Oncol Biol Phys 2011; 80(5):1412-22.

Murphy JD, La TH, Chu K, Quon A, Fischbein NJ, Maxim P, Graves EE, Le QT. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011; 80(2):514-21.

2010 and earlier

Murphy JD, Christman-Skieller C, Kim J, Dieterich S, Chang DT, Koong AC. A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 2010;78(5):1420-6.

Murphy JD, Spalding AC, Somnay YR, Markwart S, Patil S, Ray ME, Hamstra DA. Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature. Clin Cancer Res 2009;15(2):589-596.

Murphy JD, Lucas DR, Somnay YR, Hamstra DA, Ray ME. Gemcitabine-mediated radiosensitization of human soft tissue sarcoma. Translational Oncology 2008;1(1):50-56.

Feng M*,Murphy JD*  (co-first authorship), Griffith KA, Baker LH, Sondak VK, Lucas DR, McGinn CJ, Ray ME. Long-term outcomes after radiation therapy for retroperitoneal and deep truncal sarcoma. Int J Radiat Oncol Biol Phys 2007;69(1):103-110.

Murphy JD, Adusumilli S, Griffith KA, Zalupski MM, Lawrence TS, Ben-Josef E. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2007;68(3):801-808.